Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Current Taxes (2024 - 2025)

Kura Oncology (KURA) has disclosed Current Taxes for 2 consecutive years, with $239000.0 as the latest value for Q4 2025.

  • Quarterly Current Taxes fell 88.4% to $239000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $239000.0 through Dec 2025, down 88.4% year-over-year, with the annual reading at $239000.0 for FY2025, 88.4% down from the prior year.
  • Current Taxes for Q4 2025 was $239000.0 at Kura Oncology, down from $2.3 million in the prior quarter.
  • The five-year high for Current Taxes was $2.3 million in Q1 2025, with the low at $239000.0 in Q4 2025.